Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim to Use ChemAxon's Cheminformatics Software for Drug Research

Premium

ChemAxon said this week that Boehringer Ingelheim will use its cheminformatics platform to store, search, and visualize chemical entities, properties, and reactions as part of its internal and external drug research and development efforts.

ChemAxon said that Boehringer chose its software after evaluating factors such as its return on investment, performance, robustness, and scalability.

Other pharmaceutical companies that use ChemAxon's software include Japan's Eisai, which licensed its JChem Cartridge database management and search tool (BI 1/6/2012); and Pfizer, which licensed its platform to help with Markush structure searching (BI 1/22/2010).

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.